CLONIDINE patch how supplied storage and handling: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
(Created page with "__NOTOC__ {{Clonidine}} {{CMG}}; {{AE}} {{PB}} '''''For patient information, click here'''''. ==How Supplied Storage and Handling== <re...")
 
 
(5 intermediate revisions by the same user not shown)
Line 5: Line 5:
'''''For patient information, click [[Clonidine (patient information)|here]]'''''.
'''''For patient information, click [[Clonidine (patient information)|here]]'''''.


==How Supplied Storage and Handling==
==How Supplied==


Clonidine Transdermal System, USP, 0.1 mg/day, Clonidine Transdermal System, USP, 0.2 mg/day and Clonidine Transdermal System, USP, 0.3 mg/day are supplied as 4 pouched systems and 4 adhesive covers per carton. See chart below.


<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = CLONIDINE PATCH [MYLAN PHARMACEUTICALS INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7adfc439-e6d0-4593-87dd-0eef36d33c6d | publisher =  | date =  | accessdate = 5 February 2014 }}</ref>
{|
|-
|[[Image:Clonidine3.PNG|thumb|600px]]
|-
|}


==Storage and Handling==
Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]
Address medical inquiries to: 1-877-446-3679 (1-877-4-INFO-RX)
Mylan Pharmaceuticals Inc.
Morgantown, WV 26505 U.S.A.
REVISED JANUARY 2013
CTS:R13<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = CLONIDINE PATCH [MYLAN PHARMACEUTICALS INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7adfc439-e6d0-4593-87dd-0eef36d33c6d | publisher =  | date =  | accessdate = 5 February 2014 }}</ref>


==References==
==References==

Latest revision as of 03:09, 6 February 2014

Clonidine
CATAPRES® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
CLONIDINE patch ® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
DURACLON (clonidine hydrochloride) injection® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Clonidine
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]

For patient information, click here.

How Supplied

Clonidine Transdermal System, USP, 0.1 mg/day, Clonidine Transdermal System, USP, 0.2 mg/day and Clonidine Transdermal System, USP, 0.3 mg/day are supplied as 4 pouched systems and 4 adhesive covers per carton. See chart below.

Storage and Handling

Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]

Address medical inquiries to: 1-877-446-3679 (1-877-4-INFO-RX)

Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.

REVISED JANUARY 2013 CTS:R13[1]

References

  1. ↑ "CLONIDINE PATCH [MYLAN PHARMACEUTICALS INC.]". Retrieved 5 February 2014.

Template:Antimigraine preparations

Retrieved from "https://www.wikidoc.org/index.php?title=CLONIDINE_patch_how_supplied_storage_and_handling&oldid=939113"